SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-22-074049
Filing Date
2022-11-21
Accepted
2022-11-21 09:44:55
Documents
99
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0322a1_immucell.htm   iXBRL 10-Q/A 1092855
2 CERTIFICATION f10q0322a1ex31_immucell.htm EX-31 9896
3 CERTIFICATION f10q0322a1ex32_immucell.htm EX-32 4992
  Complete submission text file 0001213900-22-074049.txt   7184425

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE iccc-20220331.xsd EX-101.SCH 94211
5 XBRL CALCULATION FILE iccc-20220331_cal.xml EX-101.CAL 26922
6 XBRL DEFINITION FILE iccc-20220331_def.xml EX-101.DEF 340431
7 XBRL LABEL FILE iccc-20220331_lab.xml EX-101.LAB 661930
8 XBRL PRESENTATION FILE iccc-20220331_pre.xml EX-101.PRE 360210
93 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322a1_immucell_htm.xml XML 1042566
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-12934 | Film No.: 221403795
SIC: 2835 In Vitro & In Vivo Diagnostic Substances